9.710USD+6.59%Mkt Cap: 513.41M $P/E: —2d ago
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internat…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap513.41M $
Enterprise Value386.51M $
Revenue (TTM)48.55M $
Gross Profit15.76M $
Net Income (TTM)-69.11M $
Revenue/Share1.000 USD
Last Price9.710 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees130
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS81727U1051
Valuation
P/E (Trailing)—
P/E (Forward)-4.53
PEG—
EV/EBITDA-3.63
EV/Revenue7.96
P/S9.61
P/B5.16
EPS (TTM)-2.17
EPS (Forward)-1.95
52W Range
4.79072% of range11.58
52W High11.58 USD
52W Low4.790 USD
Profitability
Gross Margin44.71%
Oper. Margin-248.48%
EBITDA Margin-219.40%
Profit Margin-196.03%
ROE-113.21%
ROA-54.73%
Growth
Revenue Growth117.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-59.13M $
CapEx (TTM)1.12M $
FCF Margin-122.03%
FCF Yield-11.54%
Net Debt-79.84M $
Net Debt/EBITDA0.75
Balance Sheet
Debt/Equity0.68
Current Ratio6.75
Quick Ratio6.22
Book Value/Sh1.708 USD
Cash/Share2.698 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 20, 2025
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.40 USD
Upside (mean)+38.0%
Target Range8.000 USD – 18.00 USD
$8.000+38.0% to mean$18.00
# Analysts5
Ownership
Shares Out.52.87M
Float44.31M
Insiders9.84%
Institutions39.62%
Short Interest
Short Ratio11.6d
Short % Float11.97%
Short % Out.11.66%
Shares Short6.16M
Short (prev mo.)5.79M
Technical
SMA 506.104 (+59.1%)
SMA 2006.487 (+49.7%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)652.83K
Avg Vol (10d)1.06M
Technical Indicators
RSI (14)85.3
MACD0.9038
MACD Signal0.5106
MACD Hist.+0.3932
BB Upper9.699 USD
BB Middle6.416 USD
BB Lower3.134 USD
BB Width102.32%
ATR (14)0.5285 USD
Vol Ratio (20d)1.77x